Upregulation of these miRs, found in aggressive basal-like, oestrogen receptor-negative, grade 3 breast cancers [13] and drug-resistant cell models, leads to a downregulation of EP300 and E-cadherin with initiation of an EMT [12]. This evidence concerns the gene EP300 and breast cancer.